The working group is evaluating the FDA’s ability to effectively mitigate risks and exercise oversight of vitamin, mineral, and supplement marketing and manufacturing activities, with an eye toward asking Congress to legislate an expansion of the FDA’s authority over these areas. Dive deeper into this developing issue with HBW Insight.
It's Complicated: FDA Prohibits CBD In Supplements, Enforcement Priority On Disease Claims
- Newsletter
- 3 Pages
- Global